-
Mashup Score: 1
The prospect of more consolidation among Japan’s fragmented drugstore industry is likely to boost the longer term value of major players, the Japan chief of Orbis Investment Management said.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 122J&J sues in latest bid to halt Medicare drug price negotiations - 9 month(s) ago
Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that gives the Medicare government health insurance plan the power to negotiate lower drug prices.
Source: ReutersCategories: Cardiologists, Latest HeadlinesTweet-
Big Pharma thinks US patients should pay whatever the drug companies decide to charge for a medication. I don’t agree. The US pays far more for the same drug than the EU, which means US taxpayers are subsidizing healthcare in Europe. This has to stop. https://t.co/CsyV65XZtf
-
-
Mashup Score: 3Pfizer, Flagship Pioneering to invest $100 mln in drug discovery - 9 month(s) ago
U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs for areas including internal medicine, oncology, infectious diseases and immunology.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet-
U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop up to 10 new potential drugs for areas including internal medicine, oncology, infectious diseases and immunology. https://t.co/RvdNd08w35
-
-
Mashup Score: 1The health risks of extreme heat - 9 month(s) ago
The world is baking under extreme heat – with Asia, Europe and the United States all dealing with scorching temperatures.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet-
The world is baking under extreme heat - with Asia, Europe and the United States all dealing with scorching temperatures. https://t.co/uEjdD4Nupv
-
-
Mashup Score: 0Teladoc expands Microsoft tie-up to document patient visits with AI - 9 month(s) ago
Teladoc Health is expanding a partnership with Microsoft to use the tech giant’s artificial intelligence services to automate clinical documentation on the telehealth platform, lifting its shares 6% in premarket trade.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet-
Teladoc Health is expanding a partnership with Microsoft to use the tech giant's artificial intelligence services to automate clinical documentation on the telehealth platform, lifting its shares 6% in premarket trade. https://t.co/AMAwo8gzgj
-
-
Mashup Score: 4Novartis raises 2023 forecast, maps out Sandoz spin-off - 9 month(s) ago
Novartis on Tuesday raised its full-year earnings forecast for the second time on strong drug sales and mapped out the planned separation and stock market debut of its generic medicines division Sandoz for early October.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet-
Novartis on Tuesday raised its full-year earnings forecast for the second time on strong drug sales and mapped out the planned separation and stock market debut of its generic medicines division Sandoz for early October. https://t.co/q13ZDkQWp3
-
-
Mashup Score: 1Pfizer, Flagship Pioneering to invest $100 mln for drug discovery - 9 month(s) ago
U.S. drugmaker Pfizer and venture capital firm Flagship Pioneering on Tuesday agreed to invest $100 million to discover and develop 10 new potential drugs targeting diseases with few or no treatment options.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet-
U.S. drugmaker Pfizer and venture capital firm Flagship Pioneering on Tuesday agreed to invest $100 million to discover and develop 10 new potential drugs targeting diseases with few or no treatment options. https://t.co/XcxyCedNnM
-
-
Mashup Score: 0
The U.S. Food and Drug Administration (FDA) said on Monday it had approved Sanofi and partner AstraZeneca’s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.
Source: ReutersCategories: Infectious Disease, Latest HeadlinesTweet-
“Unlike Synagis, which is given as monthly injections, Beyfortus is a long-acting therapy that can be given once every season to prevent infection regardless of additional medical conditions in infants” https://t.co/9mwq7aGvaV
-
-
Mashup Score: 0
Medical equipment maker Getinge on Tuesday reported a sharp drop in second-quarter core profit, hit by quality and supply chain problems in its Cardiac Assist and Cardiopulmonary product categories.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet-
Medical equipment maker Getinge on Tuesday reported a sharp drop in second-quarter core profit, hit by quality and supply chain problems in its Cardiac Assist and Cardiopulmonary product categories. https://t.co/FK6pVi7FRU
-
-
Mashup Score: 1Novartis raises 2023 forecast, maps out Sandoz spin-off - 9 month(s) ago
Novartis on Tuesday raised its full-year earnings forecast on strong drug sales and mapped out the planned separation and stock market debut of its generic medicines division Sandoz for early October.
Source: ReutersCategories: General Medicine News, Latest HeadlinesTweet-
Novartis on Tuesday raised its full-year earnings forecast on strong drug sales and mapped out the planned separation and stock market debut of its generic medicines division Sandoz for early October. https://t.co/LzGxGdD7PZ
-
The prospect of more consolidation among Japan's fragmented drugstore industry is likely to boost the longer term value of major players, the Japan chief of Orbis Investment Management said. https://t.co/7t6EqJsIEw